NASDAQ:RAIN

Rain Therapeutics Stock Forecast

etoro logo Buy RAIN
*Your capital is at risk
$2.30
+0.370 (+19.17%)
At Close: Jun 29, 2026
AI Analysis AI Analysis of RAIN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAIN to Watchlist?
Some Reasons Why To Add RAIN:
  • Lower volatility than the market (beta -0.27)
  • Strong return on equity of 85.3%
  • Highly efficient cash conversion (130% FCF/OCF ratio)
PDF

High volatility in Rain Therapeutics Inc. stock price on Monday which ended trading at $2.30
(Updated on Jun 29, 2026)

Buy candidate since Jun 29, 2026

The Rain Therapeutics Inc. stock price gained 19.17% on the last trading day (Monday, 29th Jun 2026), rising from $1.93 to $2.30. During the last trading day the stock fluctuated 31.38% from a day low at $1.88 to a day high of $2.47. The price has fallen in 6 of the last 10 days but is still up by 12.75% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 61 thousand more shares were traded than the day before. In total, 83 thousand shares were bought and sold for approximately $191.54 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $2.28, a level that may pose a second chance to hit a runner. According to fan-theory $3.57 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

RAIN Signals & Forecast

The Rain Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.05 and $2.03. A breakdown below any of these levels will issue sell signals. Rain Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -6.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Rain Therapeutics Inc. stock

Rain Therapeutics Inc. finds support from accumulated volume at $2.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.590 between high and low, or 31.38%. For the last week, the stock has had daily average volatility of 17.81%.

Our recommended stop-loss: $2.20 (-4.20%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (RAIN) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Rain Therapeutics Inc. to open at $2.22, and during the day (based on 14 day Average True Range), to move between $2.15 and $2.45, which gives a possible trading interval of +/-$0.306 (+/-14.27%) up or down from last closing price. If Rain Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 14.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.31 (0.43%) than the support at $2.23 (3.04%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rain Therapeutics Inc. stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.131 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 30, 2026 - $2.22 ( 3.62%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAIN Performance

Trading levels for RAIN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.81 22.03%
R2 2.58 12.23%
R1 2.44 6.18%
Price 2.30
S1 1.99 -13.42%
S2 1.85 -19.48%
S3 1.63 -29.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.45 6.52%
R2 2.32 0.87%
R1 2.31 0.435%
Price 2.30
S1 2.23 -3.04%
S2 2.06 -10.43%
S3 2.02 -12.17%

FAQ

What is the symbol for Rain Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Rain Therapeutics Inc. is RAIN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rain Therapeutics Inc. Stock?
Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Rain Therapeutics Inc. Stock?
Rain Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rain Therapeutics Inc. Stock.

What's the current price of Rain Therapeutics Inc. Stock?
As of the end of day on the Jun 29, 2026, the price of an Rain Therapeutics Inc. (RAIN) share was $2.30.

What is the 52-week high and low for Rain Therapeutics Inc. Stock?
The 52-week high for Rain Therapeutics Inc. Stock is $8.50 and the 52-week low is $1.26.

What is the market capitalization of Rain Therapeutics Inc. Stock?
As of the Jun 29, 2026, the market capitalization of Rain Therapeutics Inc. is 18.701M.
Click to get the best stock tips daily for free!
ABOUT RAIN THERAPEUTICS INC.
Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinica...
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE